E-LIB Suche - Ergebnisse für: Molnár, T

1

P421 The faecal biomarker LDN-051 is a novel tool for monit..:

Jójárt, B ; Resál, T ; Diána, K...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i869-i869 , 2024

2

P621 Safety and effectiveness of vedolizumab and ustekinuma..:

Holvoet, T ; Verstockt, B ; Lenfant, M...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1195-i1196 , 2024

Link: https://doi.org/10.1093/..

3

P661 Ustekinumab in Crohn's disease: A three-year multicent..:

Barkai, L J ; Gonczi, L ; Farkas, K...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1259-i1259 , 2024

Link: https://doi.org/10.1093/..

4

P508 Pre-operative exposure to tofacitinib is as safe as bi..:

Dragoni, G ; Innocenti, T ; Amiot, A...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1005-i1006 , 2024

Link: https://doi.org/10.1093/..

5

P1016 Real-world data on sequential therapy in moderate-to-..:

Farkas, B ; Borsos, M ; Resál, T...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1837-i1838 , 2024

Link: https://doi.org/10.1093/..

6

P560 The impact of reactive point-of-care drug level measur..:

Ivány, E ; Farkas, B ; Resál, T...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1097-i1097 , 2024

Link: https://doi.org/10.1093/..

7

P938 Effectiveness and safety of switching from original in..:

Resál, T ; Bacsur, P ; Pápista, M...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1706-i1707 , 2024

Link: https://doi.org/10.1093/..

8

BOC.03.3: TREATMENT OF ANTIBIOTIC REFRACTORY CHRONIC POUCHI..:

Testa, G. ; Ribaldone, D.G. ; Verstockt, B....
Digestive and Liver Disease. 56 (2024) - p. S115-S116 , 2024

Link: https://doi.org/10.1016/..

9

P356 Long-term outcome of UC patients in clinical remission..:

Bacsur, P ; Wetwittayakhlang, P ; Resál, T...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i759-i760 , 2024

Link: https://doi.org/10.1093/..

10

P1141 Global perspectives on managing Inflammatory Bowel Di..:

Casanova, M J ; Gisbert, J P ; Amiot, A...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i2042-i2044 , 2024

Link: https://doi.org/10.1093/..

11

P735 JAK inhibitors and S1P receptor modulators for the tre..:

Testa, G ; Ribaldone, D G ; Verstockt, B...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1377-i1379 , 2024

Link: https://doi.org/10.1093/..

12

P674 Real-world experiences of switching to subcutaneous fo..:

Bacsur, P ; Resál, T ; Farkas, B...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1279-i1280 , 2024

Link: https://doi.org/10.1093/..

13

P663 Efficacy of jak inhibitors in inflammatory bowel disea..:

Livne Margolin, M ; González Lama2, Y ; Koutroubakis, I...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1261-i1263 , 2024

Link: https://doi.org/10.1093/..

14

P845 Vedolizumab induces endoscopic healing uniformly irres..:

Hens, B ; Oldenburg, L ; Molnár, T...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1570-i1571 , 2024

Link: https://doi.org/10.1093/..

15

P576 Endoscopic healing with vedolizumab in Crohn's disease..:

D'Haens, G ; Bossuyt, P ; Baert, F...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i704-i705 , 2023

Link: https://doi.org/10.1093/..